Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors.
Goldstein
M G
MG
Brown University Program in Medicine, Providence, Rhode Island.
Guttmacher
L B
LB
D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002317:Cardiovascular Agents / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D006331:Heart Diseases / Q000523:psychology*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D012307:Risk Factors
D000928:Antidepressive Agents; D002317:Cardiovascular Agents; D008996:Monoamine Oxidase Inhibitors